These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Attenuation of diabetes-associated mesenteric vascular hypertrophy with perindopril: morphological and molecular biological studies. Cooper ME; Cao Z; Rumble JR; Jandeleit K; Allen TJ; Gilbert RE Metabolism; 1998 Dec; 47(12 Suppl 1):24-7. PubMed ID: 9867067 [TBL] [Abstract][Full Text] [Related]
4. Diabetic vascular hypertrophy and albuminuria: effect of angiotensin converting enzyme inhibition. Allen TJ; Hulthen UL; Rumble JR; Jasik M; Cooper ME J Diabetes Complications; 1995; 9(4):318-22. PubMed ID: 8573756 [TBL] [Abstract][Full Text] [Related]
5. Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat. Rumble JR; Komers R; Cooper ME J Hypertens; 1996 May; 14(5):601-7. PubMed ID: 8762203 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme inhibition and calcium antagonism attenuate streptozotocin-diabetes-associated mesenteric vascular hypertrophy independently of their hypotensive action. Cao Z; Hulthén UL; Allen TJ; Cooper ME J Hypertens; 1998 Jun; 16(6):793-9. PubMed ID: 9663919 [TBL] [Abstract][Full Text] [Related]
7. Long-term effects of the endothelin(A) receptor antagonist LU 135252 and the angiotensin-converting enzyme inhibitor trandolapril on diabetic angiopathy and nephropathy in a chronic type I diabetes mellitus rat model. Dhein S; Hochreuther S; Aus Dem Spring C; Bollig K; Hufnagel C; Raschack M J Pharmacol Exp Ther; 2000 May; 293(2):351-9. PubMed ID: 10773002 [TBL] [Abstract][Full Text] [Related]
8. Vascular changes in the diabetic kidney: effects of ACE inhibition. Vranes D; Dilley RJ; Cooper ME J Diabetes Complications; 1995; 9(4):296-300. PubMed ID: 8573751 [TBL] [Abstract][Full Text] [Related]
9. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade. Hulthén UL; Cao Z; Rumble JR; Cooper ME; Johnston CI Am J Hypertens; 1996 Sep; 9(9):895-901. PubMed ID: 8879346 [TBL] [Abstract][Full Text] [Related]
11. Vascular effects of perindopril: from experimental to clinical investigation. Scalbert E; Levy B; Desche P; Devissaguet M; Safar ME J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S25-32. PubMed ID: 1725197 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme inhibition reduces the expression of transforming growth factor-beta1 and type IV collagen in diabetic vasculopathy. Rumble JR; Gilbert RE; Cox A; Wu L; Cooper ME J Hypertens; 1998 Nov; 16(11):1603-9. PubMed ID: 9856360 [TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction. Duncan AM; Burrell LM; Kladis A; Campbell DJ J Cardiovasc Pharmacol; 1996 Dec; 28(6):746-54. PubMed ID: 8961071 [TBL] [Abstract][Full Text] [Related]
14. Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes. Rumble JR; Doyle AE; Cooper ME Am J Hypertens; 1995 Jan; 8(1):53-7. PubMed ID: 7734098 [TBL] [Abstract][Full Text] [Related]
15. Antihypertensive therapy and diabetic microvascular disease. Cooper ME Clin Exp Hypertens; 1997; 19(5-6):769-78. PubMed ID: 9247754 [TBL] [Abstract][Full Text] [Related]
16. The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy. O'Brien RC; Cooper ME; Jerums G; Doyle AE Diabetes; 1993 Apr; 42(4):604-9. PubMed ID: 8454112 [TBL] [Abstract][Full Text] [Related]
17. Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery. Chiba K; Moriyama S; Ishigai Y; Fukuzawa A; Irie K; Shibano T Br J Pharmacol; 1994 Jul; 112(3):837-42. PubMed ID: 7921610 [TBL] [Abstract][Full Text] [Related]
18. Protective effect of the angiotensin-converting enzyme inhibitor perindopril on diabetic glomerulopathy in streptozotocin-induced diabetic rats. Yan L; Yang R; Cheng H; Fu Z; Zhong G; Yan T Chin Med J (Engl); 1998 Apr; 111(4):306-8. PubMed ID: 10374392 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin converting enzyme inhibition and arterial endothelial function in adults with Type 1 diabetes mellitus. McFarlane R; McCredie RJ; Bonney MA; Molyneaux L; Zilkens R; Celermajer DS; Yue DK Diabet Med; 1999 Jan; 16(1):62-6. PubMed ID: 10229295 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II? O'Sullivan JB; Black MJ; Bertram JF; Bobik A J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]